# Saga University

Organization · id `cardio:org-saga-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04f4wg107](<https://ror.org/04f4wg107>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04f4wg107 by an exact name.

## The registry's words

- Sponsor name: Saga University
- Sponsor class: OTHER
- ROR name: Saga University

## Connected pages

- Sponsors: Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER) (`cardio:ct-nct05164653`)
- Sponsors: Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) (`cardio:ct-nct05887817`)
- Sponsors: Effect of Dotinurad in Hyperuricemia With Hypertension (`cardio:ct-nct06834230`)

## Provenance

Content hash: 05eb580c26a0947cec0a60f3094cbd174c7fef46b79b4470c0a852bef7df740b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
